Provided by Tiger Trade Technology Pte. Ltd.

Goldman Sachs Future Health Care Equity ETF

37.25
+0.41221.12%
Post-market: 36.84-0.4122-1.11%16:10 EDT
Volume:29
Turnover:1K
Market Cap:19.56M
PE:- -
High:37.25
Open:36.84
Low:37.25
Close:36.84
52wk High:38.66
52wk Low:31.32
Shares:525.00K
Float Shares:525.00K
Volume Ratio:0.04
T/O Rate:0.01%
Dividend:0.11
Dividend Rate:0.31%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

When Weight Loss Isn't the Goal of Taking a GLP-1

Dow Jones
·
3 hours ago

Guardant Health Director Tariq Musa Sells 116 Common Shares for $20,300

Reuters
·
6 hours ago

Estee Lauder Cos. Cl a Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
7 hours ago

PepsiCo Adds Johnson & Johnson CEO Joaquin Duato to Board, Names Him to Audit Committee

Reuters
·
7 hours ago

Eli Lilly & Co. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
7 hours ago

Ultragenyx confirms FDA approval of Fayuvi

TIPRANKS
·
8 hours ago

Longeveron Stock (LGVN) Plummets 56% on a Failed Clinical Trial

TIPRANKS
·
11 hours ago

Moderna: Another Day, Another Big Stock Move. is the Cancer Vaccine Rally Back On?

Dow Jones
·
11 hours ago

US Health Secretary Kennedy Jr. Adds Eight New Members to Key Health Committee

Reuters
·
Yesterday

Guardant Health on Track for Record High Close

Dow Jones
·
Yesterday

Goldman Sachs Adjusts Eli Lilly Price Target to $1,371 From $1,367, Maintains Buy Rating

MT Newswires Live
·
Yesterday

Hemab Therapeutics doses first patient in HMB-003 trial

TIPRANKS
·
Yesterday

Nuvation Bio announces FDA approval of sNDA for Ibtrozi

TIPRANKS
·
Yesterday

Fennec presents results from STS-J01 clinical trial evaluating Pedmark

TIPRANKS
·
Yesterday

Bayer receives FDA approval for Kerendia for CKD with type 1 diabetes

TIPRANKS
·
Yesterday

Guizhou Bailing Unit Gets China Regulator's Nod to Trial Tangning Tongluo Cream

MT Newswires Live
·
Yesterday

GenScript Biotech Hits Near 5-Year High on Eli Lilly Collaboration

Reuters
·
Yesterday

Mountain County Embraces a New Wave of Technological Innovation

Deep News
·
Yesterday

Longeveron’s laromestrocel did not meet primary endpoint in Phase 2b HLHS trial

TIPRANKS
·
Yesterday

These ETFs Could Thrive in a Market Overcome by Interest-Rate Worries

Dow Jones
·
Yesterday